Nuclear factor-kappa B is not involved in titanium dioxide-induced inflammation

Area of Science:

• Toxicology
• Cell Biology
• Nanotechnology

Background:

• Titanium dioxide nanoparticles (TiO2 NPs) are known to induce inflammation in various cell types.
• The precise mechanisms underlying TiO2 NP-induced inflammation, particularly the role of oxidative stress and nuclear factor-kappa B (NF-kappaB) signaling, require further elucidation.

Purpose of the Study:

• To investigate the involvement of NF-kappaB in TiO2 nanoparticle-induced inflammation in human lung cells.
• To determine if NF-kappaB activation is a key pathway mediating the inflammatory response to TiO2 NPs.

Main Methods:

• Human lung adenocarcinomic epithelial cells (A549) were treated with varying concentrations of P25 TiO2 NPs (10, 50, and 250 microg/ml) for 24 hours.
• Interleukin-8 (IL-8) protein release was measured as an indicator of inflammation.
• NF-kappaB DNA binding activity was assessed after 6 hours of incubation with P25 TiO2 NPs.

Main Results:

• TiO2 NPs significantly increased IL-8 protein release in A549 cells in a dose-dependent manner.
• This finding confirms that TiO2 NPs induce inflammation in lung epithelial cells.
• No significant effect on NF-kappaB DNA binding was observed after 6 hours of TiO2 NP exposure.

Conclusions:

• TiO2 nanoparticles induce inflammation in human lung cells, evidenced by increased IL-8 release.
• NF-kappaB DNA binding is not the primary transcription pathway responsible for TiO2-induced inflammation in this cellular model.
• Further research is needed to identify the specific molecular mechanisms driving TiO2 NP-induced inflammation.